Munk Natalie bought MYGN
February 7, 2025 · Form 4 insider transaction
Munk Natalie bought 3,316 shares of Myriad Genetics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 25 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,316
Price
$0.00
Total value
N/A
InsiderMunk Natalie
Role—
CompanyMyriad Genetics, Inc. (MYGN)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 7, 2025
Filing dateMarch 4, 2025
Shares owned after46,575
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Consists of performance-based restricted stock units (PSUs) initially granted on March 22, 2022, subject to accomplishment of pre-determined performance metrics. On February 7, 2025, the Compensation and Human Capital Committee of the Company's Board of Directors determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock and vests on March 22, 2025.